These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 17706944)

  • 1. Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis.
    Mukherjee D; DiVincenzo MJ; Torok M; Choueiry F; Kumar RJ; Deems A; Miller JL; Hinton A; Geraghty C; Maranon JA; Kulp SK; Coss C; Carson WE; Conwell DL; Hart PA; Cooperstone JL; Mace TA
    Sci Rep; 2020 Dec; 10(1):21824. PubMed ID: 33311549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis.
    Katiyar D; Singhal S; Bansal P; Nagarajan K; Grover P
    3 Biotech; 2023 Feb; 13(2):62. PubMed ID: 36714551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.
    Nelson AT; Trotti D
    Neurotherapeutics; 2022 Jul; 19(4):1102-1118. PubMed ID: 35773551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review.
    Carrera-Juliá S; Moreno ML; Barrios C; de la Rubia Ortí JE; Drehmer E
    Front Physiol; 2020; 11():63. PubMed ID: 32116773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy metabolism in ALS: an underappreciated opportunity?
    Vandoorne T; De Bock K; Van Den Bosch L
    Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.
    Tefera TW; Borges K
    Front Neurosci; 2016; 10():611. PubMed ID: 28119559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
    Perera ND; Turner BJ
    Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates.
    Netzahualcoyotzi C; Tapia R
    Acta Neuropathol Commun; 2015 May; 3():27. PubMed ID: 25968178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
    PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis.
    Eitan E; Tichon A; Gazit A; Gitler D; Slavin S; Priel E
    EMBO Mol Med; 2012 Apr; 4(4):313-29. PubMed ID: 22351600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One universal common endpoint in mouse models of amyotrophic lateral sclerosis.
    Solomon JA; Tarnopolsky MA; Hamadeh MJ
    PLoS One; 2011; 6(6):e20582. PubMed ID: 21687686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis.
    Deitch JS; Alexander GM; Bensinger A; Yang S; Jiang JT; Heiman-Patterson TD
    PLoS One; 2014; 9(6):e99879. PubMed ID: 24945277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
    Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N
    Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis.
    Esposito E; Capasso M; di Tomasso N; Corona C; Pellegrini F; Uncini A; Vitaglione P; Fogliano V; Piantelli M; Sensi SL
    Brain Res; 2007 Sep; 1168():90-6. PubMed ID: 17706944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
    Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
    Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.